STOK – stoke therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Stoke Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Stoke Therapeutics (NASDAQ:STOK) was given a new $50.00 price target on by analysts at UBS Group AG.
Stoke Therapeutics (NASDAQ:STOK) had its price target raised by analysts at HC Wainwright from $35.00 to $50.00. They now have a "buy" rating on the stock.
Stoke Therapeutics' Chief Medical Officer Sold Over 5,000 Shares in the Company. Should Shareholders Sell? [Yahoo! Finance]
Is New Neurology Data And Partnerships Altering The Investment Case For Biogen (BIIB)? [Yahoo! Finance]
Form 4 Stoke Therapeutics, Inc. For: Dec 08 Filed by: Kaye Edward M. MD
Form 4 Stoke Therapeutics, Inc. For: Dec 08 Filed by: Allan Jonathan
Form 144 Stoke Therapeutics, Inc. Filed by: Kaye Edward M. MD
Form 144 Stoke Therapeutics, Inc. Filed by: Allan Jonathan
Form 4 Stoke Therapeutics, Inc. For: Dec 03 Filed by: Ticho Barry
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.